Severe COVID-19 may raise lung cancer risk by creating a tumour-promoting lung environment after viral pneumonia, new research suggests.

People hospitalised with severe COVID-19 had a 24 per cent higher risk ...

Study to test RC220 alongside standard-of-care osimertinib to prevent or delay treatment resistance. ... Read More The post ...

Respiratory illnesses such as COVID-19 and influenza are usually thought of as short-term infections that cause fever, cough, ...

In fact, the study concluded that having a severe case of Covid-19 increased people's risk of lung cancer by some 24 percent. Not only that, but the study also found that getting vaccinated against ...

The biopsy came back positive. It’s lung cancer.” Countless people in our community hear these words no one ever expects.

A triple drug approach that blocks the KRAS pathway at three points eliminated pancreatic tumors and prevented resistance in ...

Copyright: © 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Despite this impact, Brazil ...

The selective estrogen receptor degrader giredestrant plus palbociclib (Ibrance) did not significantly improve progression-free survival (PFS) in advanced hormone receptor-positive/HER2-negative ...

Independent Data Monitoring Committee Recommends Discontinuation of Phase III Trial Following Futility AnalysisSYDNEY, AUSTRALIA, March 13, 2026 ...

A study published in the journal Science reveals how jumping fragments of human DNA, a type of genetic parasite, destabilize the cancer genome. Unstable genomes are a fertile playground for cancer ...

Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC) according to the results of an international ...